Sun Pharma's unit Taro to acquire 100% stake in Antibe Therapeutics

Quick Summary:

Don't miss the most important news and views of the day.

On the same day, Sun Pharma’s stock rose 0.38 per cent to Rs 1,763.50 apiece on Thursday.

Founded in 2009, the company is currently under court-appointed receivership and has reported no revenue for the past three years.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaCanada

Topics: Ontario Superior Court of Justice Taro Pharmaceuticals Sun Pharma stocks Pharmaceutical and healthcare portfolio

Source Website Secure: Yes (HTTPS)

News Sentiment: Positive

Fact Checked: Legitimate

Article Type: News Report

Published On: 2025-01-16 @ 17:34:37 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 234 words

Reading Time: 2 minutes read

Sentences: 10 lines

Sentence Length: 24 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 25192465

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 299 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions